| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |